These outcomes showed that vincristine has an epigenetic effect leading to significant demethylation of RUNX3 in colorectal adenocarcinoma cells that could constitute a novel strategy to treat colorectal cancer. The gene discussed is RUNX3; the disease is colorectal adenocarcinoma.